<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="370663">
  <stage>Registered</stage>
  <submitdate>17/12/2016</submitdate>
  <approvaldate>3/02/2017</approvaldate>
  <actrnumber>ACTRN12617000189325</actrnumber>
  <trial_identification>
    <studytitle>Impact of Intermittent fasting in patients with liver fibrosis </studytitle>
    <scientifictitle>Impact of Intermittent fasting on LDL cholesterol and fibrosis levels in patients with liver fibrosis</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Hepatic fibrosis</healthcondition>
    <conditioncode>
      <conditioncode1>Metabolic and Endocrine</conditioncode1>
      <conditioncode2>Metabolic disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>The subjects will perform intermittent fasting during 3 months .   Participants will consume no food or drinks asides from the exceptions listed between 20:00 and 13:00 the following day, three days per week for three months.
They could drink some Infusions, water or coffee during the period of voluntary fasting. They can not combine with milk, sweeteners like sugar, saccharin or derivatives.
Participants will fill in a table with their food diary
We´ll do a blood test before the procedure (month 0), during (2 months) and the end of the study (3 months).</interventions>
    <comparator>Subjects who do not perform intermittent fasting intervention</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Evaluate the effects during 3 months of Intermittent fasting, on changes in LDL cholesterol, using blood test. </outcome>
      <timepoint>Pre-treatment, two months  and the end of intervention. We´ll do three measurements</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Evaluate the effects of the Intermittent fasting, on severity of fibrosis, assessed by elastography</outcome>
      <timepoint>Pre-treatment, two months  and the end of intervention. We´ll do three measurements</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Evaluate the effects during 3 months of Intermittent fasting, on changes in glucose , using blood test. </outcome>
      <timepoint>Pre-treatment, two months  and the end of intervention. We´ll do three measurements</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Inclusion criteria will be subjects of both sexes who have hepatic fibrosis, aged between 18 and 65 years, must have fasted for at least 8 hours</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Subjects presenting the following could not participate in the study (i) pregnant women, (ii) psychotic problems, (iii) primary cancer or current metastases, (iv) current gastrointestinal bleeding, (v) liver transplants ( vi) polycystic liver or hepatobiliary infarction (vii) intraabdominal infection or inflammation in acute phase, (viii) decompensated heart failure (ix) subjects who are receiving chemotherapy and / or radiotherapy

</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>22/03/2017</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>100</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Spain</country>
      <state>Madrid</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Camilo Jose Cela University</primarysponsorname>
    <primarysponsoraddress> C/ Castillo de Alarcon, 49  
 Urb. Villafranca del Castillo 
 28692 Madrid   </primarysponsoraddress>
    <primarysponsorcountry>Spain</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Camilo Jose Cela University</fundingname>
      <fundingaddress>  C/ Castillo de Alarcon, 49  
 Urb. Villafranca del Castillo   · 
  28692 Madrid   </fundingaddress>
      <fundingcountry>Spain</fundingcountry>
    </fundingsource>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Hospital Clinico San Carlos</fundingname>
      <fundingaddress>Calle del Prof Martin Lagos, s/n, 28040 Madrid</fundingaddress>
      <fundingcountry>Spain</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>Hospital Clinico San Carlos</sponsorname>
      <sponsoraddress>Calle del Prof Martin Lagos, s/n, 28040 Madrid</sponsoraddress>
      <sponsorcountry>Spain</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The Impact of Intermittent fasting has been recommended in several types of disorders in order to increase and improve the liver function. However, there are no studies to support its effectiveness. Therefore, through the Doppler ultrasound, we inten to evaluate the effect of Impact of Intermittent fasting on changes in LDL cholesterol and glucose in patients with liver fibrosis. The conceptual hypothesis of our study will be that "the  Intermittent fasting improves LDL cholesterol and glucose," so that Intermittent fasting may change the function of the viscera itself.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Camilo Jose Cela University</ethicname>
      <ethicaddress>·   C/ Castillo de Alarcon, 49  
 Urb. Villafranca del Castillo
  28692 Madrid   </ethicaddress>
      <ethicapprovaldate>18/04/2016</ethicapprovaldate>
      <hrec />
      <ethicsubmitdate>14/04/2016</ethicsubmitdate>
      <ethiccountry>Spain</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Prof</title>
      <name>Alvaro Otero  Campos</name>
      <address>Camilo Jose Cela University
C/ Castillo de Alarcon, 49
Urb. Villafranca del Castillo
28692 Madrid</address>
      <phone>+34618910140</phone>
      <fax />
      <email>aotero@ucjc.edu</email>
      <country>Spain</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Alvaro Otero Campos</name>
      <address>Camilo Jose Cela University
C/ Castillo de Alarcon, 49
Urb. Villafranca del Castillo
28692 Madrid</address>
      <phone>+34618910140</phone>
      <fax />
      <email>aotero@ucjc.edu</email>
      <country>Spain</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Juan Pablo Hervas</name>
      <address>Camilo Jose Cela University
C/ Castillo de Alarcon, 49
Urb. Villafranca del Castillo
28692 Madrid</address>
      <phone>+34639136120</phone>
      <fax />
      <email>jphervas@ucjc.edu</email>
      <country>Spain</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Prof</title>
      <name>Álvaro Otero Campos</name>
      <address>Camilo Jose Cela University
C/ Castillo de Alarcon, 49
Urb. Villafranca del Castillo
28692 Madrid</address>
      <phone>+34618910140</phone>
      <fax />
      <email>aotero@ucjc.edu</email>
      <country>Spain</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>